AstraZeneca boosts early respiratory medicine with Pieris deal Ruby Khatun Khatun4 May 2017 11:33 AM ISTAstraZeneca boosted its early-stage respiratory medicine pipeline on Wednesday by signing a deal with Pieris Pharmaceuticals to develop novel inhaled...
Bayer, J&J win first trial over Xarelto bleeding risks Ruby Khatun Khatun4 May 2017 11:27 AM ISTA federal jury has cleared Bayer AG and Johnson & Johnson of liability in the first trial to flow out of thousands of lawsuits blaming injuries on...
Amgen Announces Expanded Commercial Collaboration With Novartis For Erenumab In Migraine Ruby Khatun Khatun4 May 2017 11:27 AM ISTCollaboration Designed to Maximize the Launch of First-in-Class Program and to More Effectively Reach People Living With MigraineTHOUSAND OAKS,...
Visakhapatnam: Two killed in pharma unit fire Ruby Khatun Khatun4 May 2017 11:24 AM ISTVisakhapatnam: Two persons died and three others received burn injuries in a fire at a pharma unit near here on Tuesday, police said.The fire broke...
Artificial Heart Maker gets approval to resume artificial heart implants trial Ruby Khatun Khatun3 May 2017 12:12 PM ISTArtificial heart maker Carmat has obtained approval from France's national drugs agency (ANSM) to resume heart implant trials, the company said on...
SeQuent's arm Alivira gets USFDA nod for Visakhapatnam API facility Ruby Khatun Khatun3 May 2017 11:53 AM ISTNew Delhi: Drug firm SeQuent Scientific said its arm Alivira has received approval from the US health regulator for its animal health API facility in...
Abbott, Johnson & Johnson locked in tussle with govt over stent price cap Ruby Khatun Khatun3 May 2017 11:48 AM ISTNew Delhi/Mumbai: A group of global medical technology companies plans to tell Indian officials next month that any further price control measures...
FDA OKs immune-boosting drug for advanced bladder cancer Ruby Khatun Khatun3 May 2017 10:14 AM ISTTRENTON, N.J.: U.S. regulators have approved a new drug that harnesses the immune system to treat bladder cancer that has spread after chemotherapy...
AstraZeneca immunotherapy wins first approval in bladder cancer Ruby Khatun Khatun3 May 2017 9:23 AM ISTBy Ben Hirschler, Divya and GroverU.S. regulators have approved AstraZeneca's key immunotherapy drug durvalumab as a treatment for bladder cancer,...
HC notice to SBI on plea for reimbursing cancer drug cost Ruby Khatun Khatun2 May 2017 11:26 AM ISTMumbai: The Bombay High Court has sought the SBI stand on a senior citizen's plea for reimbursement of Rs six lakh as the cost of importing a cancer...
Stent makers demand government to apply differential pricing for Drug-eluting stents Ruby Khatun Khatun2 May 2017 11:24 AM ISTNew Delhi: Stent manufacturers want the government to apply differential pricing for drug-eluting stents by classifying them on the basis of...
FDA approves Radius Health's osteoporosis drug Tymlos Ruby Khatun Khatun2 May 2017 11:14 AM ISTThe U.S. Food and Drug Administration on Friday approved Radius Health Inc's drug to treat osteoporosis in postmenopausal women at high risk of...
